Aberdeen Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $802K | Buy |
7,235
+4
| +0.1% | +$443 | 0.53% | 59 |
|
|
2025
Q1 | $810K | Buy |
7,231
+3
| +0% | +$336 | 0.56% | 50 |
|
|
2024
Q4 | $668K | Sell |
7,228
-196
| -3% | -$18.1K | 0.46% | 63 |
|
|
2024
Q3 | $622K | Sell |
7,424
-840
| -10% | -$70.4K | 0.41% | 75 |
|
|
2024
Q2 | $567K | Buy |
8,264
+5
| +0.1% | +$343 | 0.38% | 75 |
|
|
2024
Q1 | $605K | Buy |
8,259
+805
| +11% | +$59K | 0.35% | 75 |
|
|
2023
Q4 | $604K | Sell |
7,454
-796
| -10% | -$64.5K | 0.44% | 69 |
|
|
2023
Q3 | $618K | Buy |
8,250
+4
| +0% | +$300 | 0.47% | 60 |
|
|
2023
Q2 | $635K | Buy |
8,246
+5
| +0.1% | +$385 | 0.46% | 63 |
|
|
2023
Q1 | $684K | Buy |
8,241
+4
| +0% | +$332 | 0.51% | 57 |
|
|
2022
Q4 | $707K | Sell |
8,237
-196
| -2% | -$16.8K | 0.53% | 53 |
|
|
2022
Q3 | $520K | Buy |
8,433
+3
| +0% | +$185 | 0.46% | 65 |
|
|
2022
Q2 | $521K | Buy |
8,430
+329
| +4% | +$20.3K | 0.41% | 69 |
|
|
2022
Q1 | $482K | Buy |
8,101
+164
| +2% | +$9.76K | 0.33% | 84 |
|
|
2021
Q4 | $576K | Buy |
7,937
+153
| +2% | +$11.1K | 0.38% | 74 |
|
|
2021
Q3 | $544K | Buy |
7,784
+223
| +3% | +$15.6K | 0.53% | 65 |
|
|
2021
Q2 | $521K | Buy |
7,561
+3
| +0% | +$207 | 0.48% | 69 |
|
|
2021
Q1 | $488K | Sell |
7,558
-183
| -2% | -$11.8K | 0.39% | 76 |
|
|
2020
Q4 | $451K | Sell |
7,741
-95
| -1% | -$5.54K | 0.34% | 80 |
|
|
2020
Q3 | $495K | Sell |
7,836
-852
| -10% | -$53.8K | 0.47% | 63 |
|
|
2020
Q2 | $668K | Buy |
8,688
+857
| +11% | +$65.9K | 0.72% | 47 |
|
|
2020
Q1 | $585K | Buy |
7,831
+168
| +2% | +$12.6K | 0.71% | 46 |
|
|
2019
Q4 | $498K | Buy |
+7,663
| New | +$498K | 0.37% | 69 |
|